Dana-Farber Cancer Institute

Sponsored Post

Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help

By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.

New male birth control options in the works

Women have been largely in charge of making sure unwanted pregnancies don’t happen unexpectedly due to the availability of various forms of contraception. While men have the obvious choice of using condoms or in extreme cases going for the snip (and there have been talks of a future pill-form for men), other potentially affective options […]


A whopping $53.1M Series B will help Syros Pharmaceuticals advance toward clinic for cancer

Gene regulation startup Syros Pharmaceuticals has raised a $53.1 million from 16 investors, according to regulatory filings. This financing round was led by “a large, Boston-based public investment firm,” also includes new investors Polaris Partners, Aisling Capital and Redmile Group. The current investors – Flagship Ventures, ARCH Venture Partners, WuXi PharmaTech Corporate Ventuer Fund and […]